©2024 Stanford Medicine
Treatment Alternatives in iSGS (NoAAC PR-02 Study)
Recruiting
Trial ID: NCT02481817
Purpose
The study is aimed at answering the questions; (1) How well do the most commonly used
treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each
approach?
With the results of this trial, the investigators hope to provide information to iSGS
patients: (1) Given my personal characteristics, conditions, and preferences, what should I
expect will happen to me? and (2) What are my options, and what are the potential benefits
and harms of these options?
Official Title
Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)
Stanford Investigator(s)
Edward J. Damrose, MD, FACS
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Anesthesiology, Perioperative & Pain Medicine
Eligibility
Inclusion Criteria:
- Greater than 18 years of age.
- The lesion must involve the subglottis.
Exclusion Criteria:
- Less than 18 years of age
- Patients without capacity to consent for themselves
- History of significant laryngotracheal traumatic injury.
- History of endotracheal intubation or tracheotomy within 2 years of presentation.
- Major anterior neck surgery.
- History of neck irradiation.
- History of caustic or thermal injuries to the laryngotracheal complex.
- History of a clinically diagnosed vasculitis or collage vascular disease.
- Positive antinuclear cytoplasmic antibody titers.
Intervention(s):
procedure: Endoscopic dilation of subglottic stenosis
procedure: Endoscopic resection of the stenosis
procedure: Tracheal Resection
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
650-723-5281